Our Services
Medical Information
Helpful Resources
Published on: 10/1/2026
Most adults ages 50 and older should get two doses of the Shingrix vaccine, as should adults 19 and older who are immunocompromised, even if they have already had shingles, previously received Zostavax, or do not recall having chickenpox. Those who should wait include people with an active shingles rash, anyone currently moderately or severely ill, people who are pregnant or breastfeeding, and anyone who had a severe allergic reaction to a vaccine component or to a first dose. Timing between doses, your medications, and your immune status all change the recommendation, so review the full details below before deciding. If you are weighing vaccination because of pain, tingling, burning, or a rash you cannot explain, a free, instant online symptom check can help you understand what your symptoms may indicate and how urgently you should act. It takes only a few minutes, is available anytime without an appointment, and gives you clear, personalized next steps to discuss with your doctor, which matters because shingles treatment works best when started within 72 hours.
Last reviewed for medical accuracy: 10/01/2026
Shingles (herpes zoster) is a painful reactivation of the chickenpox virus (varicella zoster virus) that can strike anyone who’s had chickenpox. While most people recover in a few weeks, some develop postherpetic neuralgia—a chronic nerve pain that can last months or even years.
The good news: There’s a highly effective vaccine (Shingrix) that cuts your chances of shingles by about 90%. Below, you’ll find clear guidance—based on recommendations from the Centers for Disease Control and Prevention (CDC) and other trusted medical sources—on who should get vaccinated now, and who should delay.
If your immune system is compromised—due to HIV, chemotherapy, radiation, certain medications (e.g., high-dose steroids, biologics), or organ/stem cell transplant—you’re at higher risk for severe shingles. The CDC’s Advisory Committee on Immunization Practices (ACIP) now recommends Shingrix for immunocompromised adults as young as 19.
Zostavax (the older live vaccine) was less effective over time. If you got Zostavax more than two years ago, you should still get Shingrix to boost your protection.
Many adults may not recall having chickenpox as a child. If you’re uncertain, you don’t need a blood test—just proceed with vaccination if you’re in an eligible age or risk group.
Bottom Line:
• Age ≥ 50? Get two doses of Shingrix.
• Age 19–49 with immune compromise? Get two doses.
• Previously had shingles or Zostavax? Still get Shingrix.
Most people can safely receive Shingrix. A few situations call for delaying or skipping vaccination until the issue resolves:
If you’re having a moderate or severe acute illness (e.g., high fever, severe infection), it’s best to wait until you’ve recovered. Once you’re well, you can schedule your first dose.
If you currently have shingles or are being treated for it, wait until:
If you’ve had a serious allergic reaction (anaphylaxis) to a previous dose of Shingrix or any component of the vaccine, do not receive Shingrix again. If you have questions about your allergy history, speak to your doctor.
Shingrix is not recommended for pregnant or breastfeeding women because it hasn’t been studied in these groups. If you’re pregnant or nursing:
If you’ve recently had another vaccine, your healthcare provider may space out shots by at least two weeks to monitor side effects more clearly.
Most side effects are mild to moderate and last 2–3 days:
No routine blood tests or screening is needed. Your age and health history guide the recommendation.
Consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you understand your current health status before talking with your physician.
Delaying vaccination when you’re well can leave you vulnerable to shingles, especially as you age or if your immune system changes. Likewise, rushing to vaccinate during a severe illness or active shingles may reduce vaccine effectiveness or increase side-effect risks. Following the guidelines above ensures you get the best protection at the right time.
Shingles isn’t just a rash—it can lead to long-term nerve pain that disrupts your daily life. Vaccination with Shingrix is the best way to prevent it. If you fall into any of the recommended groups (age 50+, immunocompromised 19+), make a plan to get both doses. If you’re unsure about timing or have special health concerns, consider:
Always speak to a doctor about anything serious or life-threatening, including new rashes, severe pain, or adverse reactions to a vaccine. They’ll help you make the safest, most effective choice for your health.
Stay informed. Stay protected. And don’t let shingles stand in your way.
(References)
* Schmader KE, Oxman MN, Levin MJ, Johnson G, Zhang JH, Betts R, Morrison VA, Gelb L, Guatelli JC, Harbecke R, Pachucki C, Keay S, Menzies B, Griffin MR, Kauffman C, Marques A, Toney J, Keller PM, Li X, Chan IS, Annunziato P, Shingles Prevention Study Group. Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy. Clin Infect Dis. 2012 Nov 15;55(10):1320-8. doi: 10.1093/cid/cis638. Epub 2012 Jul 24. PMID: 22828595; PMCID: PMC4542855.
* Cogman AR, Chakravarty EF. The case for Zostavax vaccination in systemic lupus erythematosus. Vaccine. 2013 Aug 12;31(36):3640-3. doi: 10.1016/j.vaccine.2013.05.085. Epub 2013 Jun 3. PMID: 23742992; PMCID: PMC3952213.
* Yun H, Xie F, Baddley JW, Winthrop K, Saag KG, Curtis JR. Longterm Effectiveness of Herpes Zoster Vaccine among Patients with Autoimmune and Inflammatory Diseases. J Rheumatol. 2017 Jul;44(7):1083-1087. doi: 10.3899/jrheum.160685. Epub 2017 Mar 15. PMID: 28298565; PMCID: PMC5724562.
* Schelling J, Rückert-Eheberg IM, Leischker AH. [Protection from a dormant time bomb: The development of effective vaccines against herpes zoster]. MMW Fortschr Med. 2017 Jun;159(10):46-48. doi: 10.1007/s15006-017-9707-1. PMID: 28550546.
* Jin J. Shingles Vaccination. JAMA. 2018 Jul 24;320(4):416. doi: 10.1001/jama.2018.7263. PMID: 30043067.
* Tafuri S, Bianchi FP, Stefanizzi P. The public health and the question of the "best vaccine". Vaccine. 2022 Jun 21;40(28):3813-3814. doi: 10.1016/j.vaccine.2022.05.044. Epub 2022 May 26. PMID: 35644671; PMCID: PMC9133921.
* Chen IL, Chiu HY. Association of herpes zoster with COVID-19 vaccination: A systematic review and meta-analysis. J Am Acad Dermatol. 2023 Aug;89(2):370-371. doi: 10.1016/j.jaad.2023.03.031. Epub 2023 Mar 30. PMID: 37001732; PMCID: PMC10060010.
* Florea A, Wu J, Qian L, Lewin B, Sy LS, Lin IC, Ku JH, Tseng HF. Risk of herpes zoster following mRNA COVID-19 vaccine administration. Expert Rev Vaccines. 2023 Jan-Dec;22(1):643-649. doi: 10.1080/14760584.2023.2232451. PMID: 37416973.
* Kennedy PGE, Grose C. Insights into pathologic mechanisms occurring during serious adverse events following live zoster vaccination. J Virol. 2025 Feb 25;99(2):e0181624. doi: 10.1128/jvi.01816-24. Epub 2025 Jan 17. PMID: 39818965; PMCID: PMC11852805.
* Herpes zoster vaccination may prevent or delay dementia. Drug Ther Bull. 2026 Mar 26;64(4):60. doi: 10.1136/dtb.2026.000005. Epub 2026 Mar 26. PMID: 41887712.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.